上海莱士:非经营性资金占用及其他关联资金往来情况汇总表

发布时间:2026-03-27 公告类型:资金占用 证券代码:002252
上海莱士血液制品股份有限公司
2025 年度非经营性资金占用及其他关联资金往来情况汇总表

                                                                                                                                          单位:人民币万元

 非经营性资金占                              占用方与上市公司 上市公司核算的会 2025 年期初              2025 年度占用累 2025 年度往来 2025 年度偿 2025 年期末往来

      用              资金占用方名称          的关联关系        计科目    往来资金余额 企业并购增加 计发生金额(不含 资金的利息(如 还累计发生    资金余额      占用形成原因      占用性质

                                                                                                              利息)          有)        金额

                海盈康(青岛)医疗科技有限        母公司          ————                                                                                              ————        ————

                公司                                                                      -          -                -            -          -              -

                                            持本公司股份 5%

 主要股东及其附 Grifols, S.A.                  以上的股东及其控    ————                                                                                              ————        ————

    属企业                                      制的公司                                  -          -                -            -          -              -

                                            持本公司股份 5%

                中信银行股份有限公司        以上的股东及其控    ————                                                                                              ————        ————

                                                制的公司                                  -          -                -            -          -              -

    小计                ————              ————        ————                -          -                -            -          -              -    ————        ————

 其他关联方及其          ————              ————        ————                                                                                              ————        ————

  附属企业                                                                              -          -                -            -          -              -

    小计                ————              ————        ————                -          -                -            -          -              -    ————        ————

    合计                ————              ————        ————                -          -                -            -          -              -    ————        ————

上海莱士血液制品股份有限公司
2025 年度非经营性资金占用及其他关联资金往来情况汇总表

                                                                                                                                          单位:人民币万元

 其它关联资金                                      往来方与上市公司的关 上市公司核算的 2025 年期初 企业并购增  2025 年度占用累 2025 年度往来 2025 年度偿 2025 年期末往

    往来                资金往来方名称                  联关系          会计科目    往来资金余      加      计发生金额(不含 资金的利息(如 还累计发生金  来资金余额  往来形成原因    往来性质

                                                                                            额                      利息)          有)          额

              中信银行股份有限公司                持本公司股份 5%以上    货币资金      38,370.64      47.13      557,409.31      208.20  576,866.50    19,168.78  资金存放    经营性往来
                                                  的股东及其控制的公司

              西藏林芝紫光药业有限责任公司        受同一最终控制方控制    应收账款              -          -        7,236.62            -    3,213.00      4,023.62  销售商品    经营性往来

              海盈康(青岛)医疗科技有限公司        母公司                  其他应收款              -          -          443.92            -            -        443.92 核心员工激励  经营性往来

              青岛市海医汇医疗科技产业创新协同中心 受同一最终控制方控制    预付账款              -          -          268.00            -            -        268.00  采购服务    经营性往来

              青岛海尔生物医疗股份有限公司        受同一最终控制方控制  其他非流动资产            -          -          336.39            -      236.03        100.36  采购商品    经营性往来

 主要股东及其 青岛场外市场清算中心有限公司        受同一最终控制方控制    预付账款              -          -            2.94            -            -          2.94  采购商品    经营性往来

  附属企业  重庆宏九医药有限公司                受同一最终控制方控制    应收账款              -          -        2,035.58            -    2,035.58            -  销售商品    经营性往来

              青岛海尔国际旅行社有限公司          受同一最终控制方控制    预付账款              -          -          260.00            -      260.00            -  接受服务    经营性往来

              基立福医药科技(上海)有限公司      持本公司股份 5%以上    预付账款              -          -          195.89            -      195.89            -  采购商品    经营性往来
                                                  的股东及其控制的公司

              青岛盈海医院有限公司                受同一最终控制方控制    应收账款            7.63          -            41.31            -        48.94            -  销售商品    经营性往来

              青岛海尔国际旅行社有限公司海尔职业培 受同一最终控制方控制    预付账款              -          -            0.26            -        0.26            -  接受服务    经营性往来
              训中心

    小计                  ————                    ————          ————      38,378.27      47.13      568,230.22      208.20  582,856.20    24,0
本报告信息基于证券交易所公开披露数据提取,由于数据抓取及清洗可能有延迟或偏差,爱金股不对内容准确性做任何保证,仅供参考。